Press Release
- - October 14, 2024
SARASOTA, Fla. and PARIS, France, October 14, 2024 -- World Precision Instruments (WPI), a leading provider of high-quality laboratory instruments and equipment for basic research and drug development, and ELVESYS, a leading microfluidic instrument manufacturer specializing in flow control and microfabrication, are excited to announce a global commercial partnership for the distribution of the ELVEFLOW family of products. This distribution partnership aims to broaden WPI's offering in fluidics, continuing to position WPI at the forefront of developing technologies that enable and augment microphysiological systems and organs-on-chip applications. With a strong focus on enabling TEER, fluidics, and other vital technologies in this field, WPI is committed to advancing research and innovation in the life sciences for basic research and drug development.
- - June 10, 2024
SARASOTA, Fla. and LYON, France, June 10, 2024 /PRNewswire/ -- World Precision Instruments (WPI), a leading provider of high-quality laboratory instruments and equipment for basic research and drug development, and NETRI, an organs-on-chip industrial start-up, are proud today to announce their partnership. This partnership aims to associate WPI's transepithelial electrical resistance (TEER) technology, and products enabling TEER, with NETRI's proprietary NeoBento organs-on-chip MultiFluidics™ line. WPI has long been at the forefront of developing technologies that enable and augment microphysiological systems and organs-on-chip applications. With a strong focus on enabling TEER, fluidics, and other vital technologies in this field, WPI is committed to advancing research and innovation in the life sciences for basic research and drug development.
- - March 20, 2024
World Precision Instruments (WPI) is pleased to announce their strategic partnership with TotalLab, paving the way for the integration of 21 CFR Part 11 compliance into its esteemed EVOM family of products.
- - November 10, 2023
SARASOTA, Fla., November 10, 2023 /PRNewswire/ -- World Precision Instruments (WPI), a leading provider of high-quality laboratory instruments and equipment for basic research and drug development, is proud to announce the establishment of its Scientific Advisory Board (SAB). Comprised of renowned experts in various scientific disciplines, the SAB will play a crucial role in guiding and advancing WPI's commitment to innovation and excellence in scientific research.
- - October 24, 2023
SARASOTA, Fla., October 23, 2023 /PRNewswire/ -- World Precision Instruments (WPI) is excited to expand the capability of the EVOM™ Auto, now offering both 24 and 96 multiwell capacity in one single platform. The EVOM™ Auto enables rapid and reproducible measurements of Transepithelial Electrical Resistance (TEER), a well-established, non-invasive and widely accepted method of evaluating epithelial and endothelial cells and tissues.
- - April 13, 2023World Precision Instruments (WPI) is excited to launch the newest member to its EVOM™ family of products, the EVOM™ Auto. The new EVOM™ Auto enables rapid and reproducible measurements of Transepithelial Electrical Resistance (TEER), a well-established and widely accepted method of evaluating epithelial and endothelial cells and tissues, in vitro. WPI’s EVOM™ Auto combines TEER technology with high throughput screening capabilities, resulting in the automated measurement of resistance in 96-well cell culture plates. This data gives scientists and drug discovery laboratories insights into tissue and monolayer barrier integrity, cell permeability, cell confluency, and can readout the critical physiology of barrier tissues such as the blood-brain barrier, the gastrointestinal tract, the lung, and the skin.
- - September 13, 2022WPI is very excited to announce our newest product launch and collaboration with MatTek Life Sciences. The companies will offer both MatTek PermaCell Cell Culture Insert Plates and compatible customized World Precision Instruments’ STX HTS EVOM™ Electrode for TEER to their respective customers, available immediately to the life sciences market.
